Significantly, it will also make CPH the only ASX-listed medicinal cannabis company with direct exposure to the Colombian market, and with the capacity to commercially cultivate medicinal-grade cannabis in the country. Colombia is one of Latin America’s rapid-growth marijuana markets. Colombians … Read More
The post Creso Pharma updates market on Colombian medical cannabis acquisition appeared first on Dagga Magazine.